💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Immunomedics, Inc. (IMMU)
« Back to company indexIMMU Chatter Timeline
Stock Ticker for IMMU
Most Active Tweeters for IMMU
| User | Tweets |
|---|---|
| @macroaxis | 1 |
| @biotechradar_eu | 1 |
| @DaiseyConnor2 | 1 |
Recent Tweets for IMMU
 |
@DaiseyConnor2 $immu Top analyst price target for next week https://t.co/hOcrnwf6As December 7th 2022, 7:12am |
 |
@biotechradar_eu Mendus $IMMU to participate in upcoming conferences in December 2022 and January 2023 https://t.co/vcegzpfJWI December 5th 2022, 1:12pm |
 |
@macroaxis Immunomedics, ( $IMMU ) social hype UNDER HYPED. Current probability of distress is under 54%… https://t.co/T7oUsO7myE November 29th 2022, 4:11pm |
|
@biotechradar_eu Mendus $IMMU to host key opinion leader event on immunotherapy for maintenance treatment of Acute Myeloid Leukemia… https://t.co/7gXvL24pSx November 16th 2022, 9:11am |
 |
@AnalyserNU Analys - Mendus No surprises in Q3 as DCP-001 readout nears https://t.co/5uMUbNr6mT $IMMU #aktieanalys November 14th 2022, 8:11am |
 |
@Biopharmaddict @Leo09416981 Yep, thank you! I mean "a la" as in decks from Sarissa Capital like those filed for $IMMU and $VRX… https://t.co/FO3IvlFA20 November 9th 2022, 10:11pm |
|
@biotechradar_eu Mendus $IMMU to present data at SITC 2022 demonstrating the potential of the DCOne platform to expand memory NK cel… https://t.co/BB53PI0AcQ November 8th 2022, 8:11am |
 |
@SADIFAnalytics Rating Update for Mendus AB (publ) $IMMU https://t.co/ckza9GwwQ0 November 7th 2022, 5:11pm |
 |
@BurchetJohn @SCalifornee @pawcio2009 Too bad you didn't hold $IMMU a bit longer...$88 BO. November 7th 2022, 1:11pm |
 |
@ziggles89 RT @BertrandBio: $IMMU Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion, Improve… November 3rd 2022, 10:11pm |
 |
@BertrandBio $IMMU Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in… https://t.co/jO2NZPwA7n November 3rd 2022, 6:11pm |
|
@BertrandBio $IMMU Use of an Allogeneic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML-Patients Results in MRD Conversion,… https://t.co/TZYzk55DVd November 3rd 2022, 6:11pm |
|
@biotechradar_eu Mendus $IMMU to present multiple abstracts at ASH 2022 including an oral presentation of updated AML survival resul… https://t.co/3GNfjIPpj1 November 3rd 2022, 3:11pm |
|
@biotechradar_eu Mendus $IMMU to participate in upcoming conferences in November https://t.co/H8mYvC6gD0 November 1st 2022, 2:11pm |
 |
@AlanGormican @sharkbiotech Long $immu October 28th 2022, 12:10pm |
|
@AnalyserNU Analys - Mendus Funding to see through key inflection points https://t.co/f8oDffcTSY $IMMU #aktieanalys October 27th 2022, 8:10am |
|
@biotechradar_eu Mendus $IMMU secures first shareholder loan from Van Herk Investments and signs final documentation with Negma Group https://t.co/EpVLUx9b0p October 26th 2022, 8:10am |
 |
@ej23ny Most recent activist contests venBio Vs $IMMU win for VenBio appointed 4 directors Velan Capital Vs $RDUS acquir… https://t.co/jC3md4PXog October 24th 2022, 3:10pm |
 |
@KempenLS #ECTRIMS2022: 26-28 Oct #ESGO2022: 27-30 Oct - $IMMU: DCP-001 ph1 ovarian cancer data - 27 Oct Roadshows $GNFT: Vi… https://t.co/JdfkBv8kIK October 24th 2022, 6:10am |
|
@BurchetJohn @pharmacreep Look what happened a couple years ago with $IMMU. It's possible $PRVB is next. October 22nd 2022, 1:10pm |
|
@biotechradar_eu Mendus $IMMU secures manufacturing partner for establishing potential pivotal trial-stage and commercial production… https://t.co/aObazmhLes October 18th 2022, 8:10am |
|
@biotechradar_eu Mendus $IMMU to report positive clinical and preclinical data in ovarian cancer at the European Society of Gynaecol… https://t.co/BIPa6NeTyq October 17th 2022, 9:10am |
|
@macroaxis IMMUNOMEDICS INC ( $IMMU ) social hype UNDER HYPED. Current chance of bankruptcy is under 54%… https://t.co/wm4AzVyLc0 October 12th 2022, 3:10pm |
|
@biotechradar_eu Mendus $IMMU to receive final payment as a result of the completion of the EU Horizon 2020 AML-VACCiN project https://t.co/vesro23o9s October 12th 2022, 10:10am |
|
@ej23ny proxy fight Activist Vs biotech Management ! Ven Advisor LLC Vs $IMMU ! 55% of /80% Cast the vote in Favor of ven… https://t.co/UblI5sqC44 October 11th 2022, 9:10pm |
|
@macroaxis Immunomedics ( $IMMU ) social hype UNDER HYPED. Current odds of distress is under 54% https://t.co/5166DvQHOe #biotech #stocks #fintech September 27th 2022, 3:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.